| Jessica L Holland, CRNA | |
|
10400 75th St, Kenosha, WI 53142 | |
| (262) 942-5600 | |
| Not Available |
| Full Name | Jessica L Holland |
|---|---|
| Gender | Female |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 9 Years |
| Location | 10400 75th St, Kenosha, Wisconsin |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225417488 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 6405 (Wisconsin) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ascension Se Wisconsin Hospital - St Joseph Campus | Milwaukee, WI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Zen Anesthesia Llc | 2567827108 | 8 |
| Anesthesia Partners Services Sc | 4082832514 | 35 |
| Wheaton Franciscan Medical Group Inc | 8628980943 | 594 |
News Archive
A new study from Lund University and Region Skåne in Sweden indicates that potency-enhancing PDE5 inhibitor drugs have an anti-cancer potential with the ability to improve the prognosis in patients with colorectal cancer.
In partnership with Corcept Therapeutics Inc., the National Organization for Rare Disorders (NORD) has established a Cushing's Syndrome Patient Assistance Program for patients with endogenous Cushing's syndrome who need financial assistance with certain costs related to their medical diagnosis and/or care.
A novel, synthetic, DNA-based strategy to provide protection against a broad array of influenza viruses has been developed in preclinical models by scientists at The Wistar Institute, MedImmune (the global biologics research and development arm of AstraZeneca) and Inovio Pharmaceuticals, Inc.
Three hours of moderate exercise per week significantly reduced circulating estrogens in postmenopausal women, according to a new study published in the current issue of Cancer Research. The finding may explain why women who exercise regularly lower their risk for breast cancer.
› Verified 3 days ago
| Entity Name | Aurora Medical Group, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427271378 PECOS PAC ID: 6709794258 Enrollment ID: O20031105000725 |
News Archive
A new study from Lund University and Region Skåne in Sweden indicates that potency-enhancing PDE5 inhibitor drugs have an anti-cancer potential with the ability to improve the prognosis in patients with colorectal cancer.
In partnership with Corcept Therapeutics Inc., the National Organization for Rare Disorders (NORD) has established a Cushing's Syndrome Patient Assistance Program for patients with endogenous Cushing's syndrome who need financial assistance with certain costs related to their medical diagnosis and/or care.
A novel, synthetic, DNA-based strategy to provide protection against a broad array of influenza viruses has been developed in preclinical models by scientists at The Wistar Institute, MedImmune (the global biologics research and development arm of AstraZeneca) and Inovio Pharmaceuticals, Inc.
Three hours of moderate exercise per week significantly reduced circulating estrogens in postmenopausal women, according to a new study published in the current issue of Cancer Research. The finding may explain why women who exercise regularly lower their risk for breast cancer.
› Verified 3 days ago
| Entity Name | Divine Savior Healthcare Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1124083894 PECOS PAC ID: 5799684007 Enrollment ID: O20040225000909 |
News Archive
A new study from Lund University and Region Skåne in Sweden indicates that potency-enhancing PDE5 inhibitor drugs have an anti-cancer potential with the ability to improve the prognosis in patients with colorectal cancer.
In partnership with Corcept Therapeutics Inc., the National Organization for Rare Disorders (NORD) has established a Cushing's Syndrome Patient Assistance Program for patients with endogenous Cushing's syndrome who need financial assistance with certain costs related to their medical diagnosis and/or care.
A novel, synthetic, DNA-based strategy to provide protection against a broad array of influenza viruses has been developed in preclinical models by scientists at The Wistar Institute, MedImmune (the global biologics research and development arm of AstraZeneca) and Inovio Pharmaceuticals, Inc.
Three hours of moderate exercise per week significantly reduced circulating estrogens in postmenopausal women, according to a new study published in the current issue of Cancer Research. The finding may explain why women who exercise regularly lower their risk for breast cancer.
› Verified 3 days ago
| Entity Name | Brookfield Anesthesiologists Sc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942257902 PECOS PAC ID: 5395847529 Enrollment ID: O20070219000542 |
News Archive
A new study from Lund University and Region Skåne in Sweden indicates that potency-enhancing PDE5 inhibitor drugs have an anti-cancer potential with the ability to improve the prognosis in patients with colorectal cancer.
In partnership with Corcept Therapeutics Inc., the National Organization for Rare Disorders (NORD) has established a Cushing's Syndrome Patient Assistance Program for patients with endogenous Cushing's syndrome who need financial assistance with certain costs related to their medical diagnosis and/or care.
A novel, synthetic, DNA-based strategy to provide protection against a broad array of influenza viruses has been developed in preclinical models by scientists at The Wistar Institute, MedImmune (the global biologics research and development arm of AstraZeneca) and Inovio Pharmaceuticals, Inc.
Three hours of moderate exercise per week significantly reduced circulating estrogens in postmenopausal women, according to a new study published in the current issue of Cancer Research. The finding may explain why women who exercise regularly lower their risk for breast cancer.
› Verified 3 days ago
| Entity Name | Racine Anesthesia Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467782748 PECOS PAC ID: 8628103777 Enrollment ID: O20100316000106 |
News Archive
A new study from Lund University and Region Skåne in Sweden indicates that potency-enhancing PDE5 inhibitor drugs have an anti-cancer potential with the ability to improve the prognosis in patients with colorectal cancer.
In partnership with Corcept Therapeutics Inc., the National Organization for Rare Disorders (NORD) has established a Cushing's Syndrome Patient Assistance Program for patients with endogenous Cushing's syndrome who need financial assistance with certain costs related to their medical diagnosis and/or care.
A novel, synthetic, DNA-based strategy to provide protection against a broad array of influenza viruses has been developed in preclinical models by scientists at The Wistar Institute, MedImmune (the global biologics research and development arm of AstraZeneca) and Inovio Pharmaceuticals, Inc.
Three hours of moderate exercise per week significantly reduced circulating estrogens in postmenopausal women, according to a new study published in the current issue of Cancer Research. The finding may explain why women who exercise regularly lower their risk for breast cancer.
› Verified 3 days ago
| Entity Name | Anesthesia Partners Services Sc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861810947 PECOS PAC ID: 4082832514 Enrollment ID: O20140826000757 |
News Archive
A new study from Lund University and Region Skåne in Sweden indicates that potency-enhancing PDE5 inhibitor drugs have an anti-cancer potential with the ability to improve the prognosis in patients with colorectal cancer.
In partnership with Corcept Therapeutics Inc., the National Organization for Rare Disorders (NORD) has established a Cushing's Syndrome Patient Assistance Program for patients with endogenous Cushing's syndrome who need financial assistance with certain costs related to their medical diagnosis and/or care.
A novel, synthetic, DNA-based strategy to provide protection against a broad array of influenza viruses has been developed in preclinical models by scientists at The Wistar Institute, MedImmune (the global biologics research and development arm of AstraZeneca) and Inovio Pharmaceuticals, Inc.
Three hours of moderate exercise per week significantly reduced circulating estrogens in postmenopausal women, according to a new study published in the current issue of Cancer Research. The finding may explain why women who exercise regularly lower their risk for breast cancer.
› Verified 3 days ago
| Entity Name | Ascension Medical Group-southeast Wisconsin Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194473066 PECOS PAC ID: 8628980943 Enrollment ID: O20220620000485 |
News Archive
A new study from Lund University and Region Skåne in Sweden indicates that potency-enhancing PDE5 inhibitor drugs have an anti-cancer potential with the ability to improve the prognosis in patients with colorectal cancer.
In partnership with Corcept Therapeutics Inc., the National Organization for Rare Disorders (NORD) has established a Cushing's Syndrome Patient Assistance Program for patients with endogenous Cushing's syndrome who need financial assistance with certain costs related to their medical diagnosis and/or care.
A novel, synthetic, DNA-based strategy to provide protection against a broad array of influenza viruses has been developed in preclinical models by scientists at The Wistar Institute, MedImmune (the global biologics research and development arm of AstraZeneca) and Inovio Pharmaceuticals, Inc.
Three hours of moderate exercise per week significantly reduced circulating estrogens in postmenopausal women, according to a new study published in the current issue of Cancer Research. The finding may explain why women who exercise regularly lower their risk for breast cancer.
› Verified 3 days ago
| Entity Name | Zen Anesthesia Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1891483368 PECOS PAC ID: 2567827108 Enrollment ID: O20230503002287 |
News Archive
A new study from Lund University and Region Skåne in Sweden indicates that potency-enhancing PDE5 inhibitor drugs have an anti-cancer potential with the ability to improve the prognosis in patients with colorectal cancer.
In partnership with Corcept Therapeutics Inc., the National Organization for Rare Disorders (NORD) has established a Cushing's Syndrome Patient Assistance Program for patients with endogenous Cushing's syndrome who need financial assistance with certain costs related to their medical diagnosis and/or care.
A novel, synthetic, DNA-based strategy to provide protection against a broad array of influenza viruses has been developed in preclinical models by scientists at The Wistar Institute, MedImmune (the global biologics research and development arm of AstraZeneca) and Inovio Pharmaceuticals, Inc.
Three hours of moderate exercise per week significantly reduced circulating estrogens in postmenopausal women, according to a new study published in the current issue of Cancer Research. The finding may explain why women who exercise regularly lower their risk for breast cancer.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jessica L Holland, CRNA 10400 75th St, Kenosha, WI 53142-7884 Ph: (262) 942-5600 | Jessica L Holland, CRNA 10400 75th St, Kenosha, WI 53142 Ph: (262) 942-5600 |
News Archive
A new study from Lund University and Region Skåne in Sweden indicates that potency-enhancing PDE5 inhibitor drugs have an anti-cancer potential with the ability to improve the prognosis in patients with colorectal cancer.
In partnership with Corcept Therapeutics Inc., the National Organization for Rare Disorders (NORD) has established a Cushing's Syndrome Patient Assistance Program for patients with endogenous Cushing's syndrome who need financial assistance with certain costs related to their medical diagnosis and/or care.
A novel, synthetic, DNA-based strategy to provide protection against a broad array of influenza viruses has been developed in preclinical models by scientists at The Wistar Institute, MedImmune (the global biologics research and development arm of AstraZeneca) and Inovio Pharmaceuticals, Inc.
Three hours of moderate exercise per week significantly reduced circulating estrogens in postmenopausal women, according to a new study published in the current issue of Cancer Research. The finding may explain why women who exercise regularly lower their risk for breast cancer.
› Verified 3 days ago
Paula Michelle Osgood, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 10400 75th St, Kenosha, WI 53142 Phone: 262-948-5600 | |
Dorothy Katherine Free, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 10400 75th St, Kenosha, WI 53142 Phone: 262-948-5600 Fax: 262-948-5735 | |
Hannah R Stewart, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 10400 75th St, Kenosha, WI 53142 Phone: 262-948-5600 Fax: 262-948-5735 | |
Alexandra M Roznowski, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 10400 75th St, Kenosha, WI 53142 Phone: 262-948-5600 | |
Theresa A. Aschenbrener, C.R.N.A. Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 6308 8th Ave, Kenosha, WI 53143 Phone: 262-656-2011 | |
Brandi M Turner, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 10400 75th St, Kenosha, WI 53142 Phone: 262-948-5600 Fax: 262-948-7388 |